Upon targeted and conventional cancer therapies, cancer cells often induce stress response to survive the cancer treatment and generate drug tolerance via heme-regulated inhibitor (HRI) kinase-ATF4 signaling [110]. Here, EIF2AK1 is linked to cancer.